Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cell Therapeutics (CTIC) -- Ignore unavailable to you. Want to Upgrade?

To: Don Hurst who wrote (727)	8/24/2005 11:59:32 AM
From: Icebrg	Read Replies (1) \| Respond to of 946

Well, they haven't filed yet. They have only said that they have decided on what to file for. And it is not entirely clear - at least not to me - if their intention is to file before or after they have the results available from their woman-only clinical trial. To sink more money into Xyotax, if they intend to file based on Stellar 3 and 4 doesn't make much sense to me. And to run the new trial before having FDA's input doesn't make much sense either. Erik